What Is Nausea of Pregnancy?
Nausea and vomiting of pregnancy (NVP), popularly called "morning sickness," affects up to 80% of pregnant women, generally starting between the 6th and 8th week of gestation. Despite the name, symptoms can occur at any time of day.
In most cases, NVP is mild to moderate and resolves spontaneously by the 16th-20th week. However, in 0.5-2% of pregnant women, it progresses to hyperemesis gravidarum (HG) — a severe form with intractable vomiting, dehydration, ketosis, and weight loss greater than 5% of pré-pregnancy weight.
Although common and generally self-limited, NVP can significantly affect quality of life, psychological well-being, and functional capacity. Underdiagnosis and undertreatment are common problems.
Common Condition
Affects up to 80% of pregnant women. Usually self-limited and poses no risk to the fetus.
Hyperemesis Gravidarum
Severe form in 0.5-2% of pregnancies, with dehydration, ketosis, and weight loss. Requires medical treatment and often hospitalization.
Time Course
Typically starts in the 6th-8th week, peaks in the 9th-12th week, and resolves by the 16th-20th week. About 10% of pregnant women have symptoms after the 20th week.
Pathophysiology
NVP pathophysiology is multifactorial, involving hormonal, gastrointestinal, vestibular, and psychological factors. Human chorionic gonadotropin (hCG) is the main candidate, since its serologic peak coincides with the peak of nausea symptoms.
Recently, the protein GDF15 (Growth Differentiation Factor 15) emerged as a key mediator of NVP. Produced in large amounts by the placenta, GDF15 acts on GFRAL receptors in the brainstem (área postrema), directly activating the emetic centers. Pregnant women with genetic variants that reduce prior exposure to GDF15 show greater susceptibility to NVP.
Hormonal and Gastrointestinal Factors
Estrogen increases the sensitivity of the vomiting center and contributes to the hyperosmia (heightened sensitivity to odors) of pregnancy. Progesterone reduces gastric motility and lower esophageal sphincter tone, favoring reflux and gastric stasis.
Risk factors for severe NVP include multiple gestation (higher hCG levels), personal or family history of NVP, history of motion sickness, migraine, female fetal sex, and molar pregnancy.
Symptoms
NVP manifests on a spectrum ranging from occasional mild nausea to the intractable vomiting of hyperemesis gravidarum. Severity is assessed by the PUQE score (Pregnancy-Unique Quantification of Emesis).
Symptoms of NVP
- 01
Persistent nausea
Present throughout the day, not only in the morning. May be triggered by odors, specific foods, or an empty stomach.
- 02
Morning vomiting
Classically in the morning, but may occur at any time. In mild-to-moderate NVP, generally 1-5 episodes per day.
- 03
Hyperosmia
Heightened sensitivity to odors — perfumes, cooking food, and previously neutral smells can trigger intense nausea.
- 04
Food aversions
Sudden aversion to previously enjoyed foods, especially meats, coffee, and fatty foods.
- 05
Ptyalism (sialorrhea)
Excessive salivation, more common in pregnant women of African descent. Can be as disabling as nausea.
- 06
Fatigue and malaise
Extreme tiredness often accompanies nausea, disrupting daily activities.
MILD-MODERATE NVP VS HYPEREMESIS GRAVIDARUM
| FEATURE | MILD-MODERATE NVP | HYPEREMESIS GRAVIDARUM |
|---|---|---|
| Prevalence | 50-80% of pregnancies | 0.5-2% of pregnancies |
| Weight loss | Minimal or absent | Greater than 5% of pré-pregnancy weight |
| Dehydration | Absent | Present, with ketonuria |
| Feeding | Partial tolerance | Intolerance to solids and, at times, liquids |
| Hospitalization | Unnecessary | Frequently necessary |
| Electrolyte disturbances | Absent | Hyponatremia, hypokalemia, alkalosis |
Diagnosis
NVP diagnosis is clinical, based on the typical history of nausea and vomiting in the first trimester. It is important to exclude other causes of vomiting, such as urinary tract infection, thyroid disease, and gestational trophoblastic disease.
In hyperemesis gravidarum, laboratory tests show ketonuria, elevated urea and creatinine (dehydration), electrolyte disturbances, often elevated hepatic transaminases, and thyroid function assessment (TSH, free T4 — elevated hCG in hyperemesis gravidarum can stimulate the thyroid, causing transient gestational thyrotoxicosis that must be differentiated from Graves disease). Ultrasonography should exclude molar pregnancy and confirm fetal viability.
🏥Criteria for Hyperemesis Gravidarum
- 1.Persistent and intractable vomiting in the first trimester
- 2.Weight loss greater than 5% of pré-pregnancy weight
- 3.Documented ketonuria
- 4.Dehydration with electrolyte disturbances
- 5.Exclusion of other causes of vomiting
DIFFERENTIAL DIAGNOSIS
Differential Diagnosis
Hyperemesis Gravidarum
- Intractable vomiting with malnutrition/dehydration
- Ketonuria
- Weight loss >5% of pré-pregnancy weight
- Severe hyperemesis = hospital admission
Diagnostic Tests
- Urinalysis
- Electrolytes
- Liver function
Pyelonephritis in Pregnancy
- Fever + dysuria + flank pain + nausea
- Leukocyturia and bacteriuria
- Gestational pyelonephritis = urgent antibiotic
Diagnostic Tests
- Urinalysis and urine culture
- Renal ultrasound
Ovarian Hyperstimulation
- Recent IVF
- Abdominal distension
- Enlarged ovaries
- Severe OHSS = hospitalization
Diagnostic Tests
- Ultrasonography
- Estradiol
Viral Gastroenteritis
- Associated diarrhea
- Fever
- Contact with sick person
- Limited duration
Diagnostic Tests
- Clinical
- Stool culture if necessary
Intrahepatic Cholestasis of Pregnancy
- Pruritus
- Mild jaundice
- Elevated AST/ALT
- 3rd trimester
- Gestational cholestasis = elevated fetal risk
Diagnostic Tests
- Liver function
- Bile acids
Hyperemesis Gravidarum: When Nausea Becomes an Emergency
Hyperemesis gravidarum (HG) is the severe extreme of the NVP spectrum — affecting 0.3-2% of pregnant women and characterized by intractable vomiting with significant nutritional and metabolic consequences: weight loss greater than 5% of pré-pregnancy weight, dehydration, ketonuria, and electrolyte imbalance. Unlike typical NVP, HG often requires hospital admission for IV hydration, thiamine (B1) replacement, and parenteral antiemetic medication.
Without adequate treatment, thiamine deficiency can lead to Wernicke encephalopathy — a severe and potentially permanent neurologic complication. Distinguishing NVP from HG is based on clinical severity and laboratory findings: positive ketonuria, low sodium and potassium, altered transaminases, and hyperbilirubinemia indicate HG. Hospitalization is the standard of care when the patient cannot tolerate oral fluids.
Pyelonephritis and Gestational Cholestasis: Diagnoses That Cannot Wait
Pyelonephritis is one of the most common severe infections in pregnancy and presents with nausea and vomiting associated with fever, chills, flank pain, and dysuria. Untreated asymptomatic bacteriuria progresses to pyelonephritis in 20-40% of pregnant women. Diagnosis is confirmed by urinalysis and urine culture — leukocyturia and bacteriuria are the findings. IV antibiotic treatment is urgent, since gestational pyelonephritis increases the risk of preterm labor, sepsis, and renal failure.
Intrahepatic cholestasis of pregnancy (ICP) occurs in the second and third trimesters and manifests with intense pruritus (especially of the palms and soles), mild jaundice, and elevated transaminases and bile acids. Nausea may accompany the presentation. The clinical importance is the fetal risk: ICP significantly increases the risk of fetal distress, late stillbirth, and preterm birth. Diagnosis is laboratory-based (bile acids >10 µmol/L), and ursodeoxycholic acid treatment is established.
Ovarian Hyperstimulation Syndrome: Context of Assisted Reproduction
Ovarian hyperstimulation syndrome (OHSS) is a complication of ovarian stimulation in assisted-reproduction protocols (IVF, IUI). It is characterized by enlarged ovaries with multiple follicular cysts, abdominal distension from ascites, and nausea/vomiting. Mild to moderate cases are managed as outpatients with hydration and rest. Severe cases (large-volume ascites, pleural effusion, thromboembolism) require hospitalization.
Distinguishing OHSS from NVP is contextual: a history of recent assisted-reproduction treatment with ovarian stimulation is essential. Ultrasonography shows enlarged ovaries and ascites, with very elevated serum estradiol. Multiple gestation (frequent after IVF) amplifies the risk of both OHSS and more intense NVP. The physician following the assisted-reproduction pregnancy should closely monitor these concurrent diagnoses.
Treatment
NVP treatment is escalated according to severity, always prioritizing fetal safety. Nonpharmacologic measures are first-line for mild NVP, while pharmacotherapy is indicated when symptoms impact feeding and quality of life.
Nonpharmacologic Measures
Small frequent meals, avoid empty stomach, ginger (250 mg 4x/day), acupressure at PC-6, avoid olfactory and food triggers.
First-Line Pharmacotherapy
Doxylamine 12.5 mg + pyridoxine (vitamin B6) 25 mg, 2-4x/day. Combination has a broad pregnancy safety profile and is FDA-approved specifically for NVP (Diclegis/Bonjesta); under the still-current Canadian classification it corresponds to Category A (the FDA discontinued the category system in 2015 with the PLLR rule).
Second Line
Ondansetron 4 mg, metoclopramide, or promethazine for moderate-severe refractory NVP. Individualized risk-benefit assessment.
Hyperemesis Gravidarum
Hospitalization for intravenous hydration, electrolyte correction, thiamine supplementation (Wernicke prevention), parenteral antiemetics, and if necessary enteral or parenteral nutrition.
Acupuncture as Treatment
Acupuncture and acupressure at the PC-6 (Neiguan) point are recommended by various obstetric guidelines as a nonpharmacologic option for NVP. The great advantage is the absence of fetal exposure to drugs, making it particularly attractive in the first trimester.
Acupressure wristbands (Sea-Band) are a practical and accessible form of PC-6 stimulation and can be worn continuously by the pregnant woman. Clinical studies show modest but consistent efficacy in reducing nausea, with a favorable safety profile and a low rate of reported adverse events.
Needle acupuncture may be more effective than acupressure in moderate cases. Weekly sessions during the nausea period, using pregnancy-specific protocols (avoiding points contraindicated in pregnancy), can complement dietary measures and reduce the need for medications.
Prognosis
NVP prognosis is excellent in the vast majority of cases. About 90% of pregnant women have complete symptom resolution by the 20th week of gestation. NVP is not associated with adverse fetal outcomes — paradoxically, some studies suggest an association with lower risk of spontaneous abortion.
Hyperemesis gravidarum, although more severe, also has a favorable prognosis with adequate treatment. Rare complications include Wernicke encephalopathy (from thiamine deficiency), central pontine myelinolysis (from rapid correction of hyponatremia), and retinal detachment.
Women with NVP in one pregnancy have a 75-85% probability of recurrence in subsequent pregnancies. Severity tends to be similar across pregnancies, which allows for prophylactic planning.
Myths and Facts
Myth vs. Fact
Morning sickness only happens in the morning
Despite the name 'morning sickness,' nausea can occur at any time of day. In many pregnant women, symptoms are worse at night or are constant throughout the day.
Pregnancy nausea is psychological — it is just complaining
NVP has well-documented hormonal and physiologic bases, involving hCG, GDF15, estrogen, and changes in gastric motility. It is not psychosomatic.
Intense nausea means the baby is sick
On the contrary, nausea is associated with adequate hCG levels and may indicate good placental implantation. Studies suggest a lower risk of miscarriage in pregnant women with NVP.
No medication is safe in pregnancy for nausea
The doxylamine + pyridoxine combination has a well-established safety profile in pregnancy (specific FDA approval for NVP; Canadian category 'A'). Important: in 2015 the FDA replaced the ABCDX category system with the PLLR rule (Pregnancy and Lactation Labeling Rule), which provides more detailed pregnancy safety information. Ondansetron and metoclopramide also have acceptable safety profiles when indicated.
Hyperemesis gravidarum is just a stronger form of morning sickness
Hyperemesis gravidarum is a severe medical condition that requires hospital treatment. It can cause severe dehydration, electrolyte disturbances, thiamine deficiency, and rarely neurologic complications.
When to Seek Help
Mild pregnancy nausea is expected and can be managed with simple measures. However, certain situations require medical evaluation to ensure the safety of the pregnant woman and the fetus.
Frequently Asked Questions about Pregnancy Nausea
Nausea and vomiting affect 70-80% of pregnant women in the first trimester and are considered normal. Intensity varies widely between women and between pregnancies in the same woman. Most cases resolve spontaneously by the 14-16th week. When vomiting is severe enough to cause weight loss greater than 5%, dehydration, or ketonuria, the diagnosis becomes hyperemesis gravidarum — a condition that requires active medical treatment, often with hospital admission.
The term 'morning sickness' is imprecise — for many women, nausea occurs throughout the day. Increased nausea in the morning is related to an empty stomach after the overnight fast (relative hypoglycemia), high hCG levels (which peak in the early weeks), and greater olfactory and gustatory sensitivity at rest. Eating something dry and easy to digest before getting out of bed (water cracker, toast) is an effective strategy to reduce morning nausea.
Yes, when performed by a physician acupuncturist experienced with pregnant patients. Acupuncture is one of the most studied interventions for pregnancy nausea — systematic reviews show superior efficacy over placebo for reducing nausea and vomiting, with no evidence of fetal harm. Specific points such as PC-6 (Neiguan) and ST-36 are used with documented safety. Some points are contraindicated in pregnancy (SP-6, LI-4 in high doses) — which is why treatment should be done exclusively with a physician acupuncturist trained in gestational integrative medicine.
The best-studied medications considered safe in pregnancy: doxylamine + pyridoxine (B6) is the first-line combination specifically approved for NVP in the US, with broad safety evidence; metoclopramide is widely used and considered safe; ondansetron is effective, but observational studies have raised inconsistent signals about a possible small increase in risk of malformations (cardiac and orofacial) with first-trimester use, requiring individualized obstetric assessment; promethazine is an option with an established safety profile. No medication should be started without obstetrician guidance.
Yes. Ginger has moderate-to-good evidence for reducing pregnancy nausea, outperforming placebo in multiple clinical trials. It can be used as tea (1-2 cm of fresh root in hot water), crystallized, in standardized capsules (250 mg 4x/day), or in cookies. The recommended safe dose is up to 1 g/day of dried ginger. Very high doses are theoretically not recommended in the first trimester, though no adverse effects have been reported at usual doses. Your obstetrician can guide individualized use.
Pyridoxine (vitamin B6) is an essential cofactor in neurotransmitter metabolism, including serotonin and dopamine, which modulate the vomiting reflex. Studies show that 25-75 mg/day of B6 reduces nausea intensity in pregnant women, especially when combined with doxylamine. It is considered safe at therapeutic doses in pregnancy. B6 combined with ginger also shows additive benefit. Supplementation should be guided by the obstetrician to avoid excessive doses.
Mild to moderate NVP does not harm the fetus — paradoxically, studies show that pregnant women with nausea have a lower risk of spontaneous abortion, possibly because nausea marks a healthy ongoing pregnancy. Severe untreated hyperemesis gravidarum can cause thiamine deficiency (risk of Wernicke encephalopathy), maternal malnutrition, and in extreme cases impaired fetal growth. With adequate treatment, fetal outcome is generally normal even in severe HG.
For most women (70-80%), nausea resolves between the 14th and 16th week. In 10-20%, symptoms persist into the third trimester, and in a small proportion (1-2%) they last the entire pregnancy. Multiple pregnancies (twins, triplets) and gestational trophoblastic disease (hydatidiform mole) are associated with more intense and prolonged NVP. If nausea begins or worsens after the 10th week, the obstetrician should investigate specific causes.
Some studies suggest an association between more intense NVP and pregnancies with female fetuses, possibly related to differences in hormone levels (slightly higher hCG in female pregnancies). However, the evidence is inconsistent across studies and small in magnitude — not reliable enough to predict fetal sex. This is a weak statistical association and should not be used for any clinical or family-planning inference.
Hospitalization is necessary when: the patient cannot keep fluids down for more than 12-24 hours; weight loss exceeds 5% of pré-pregnancy weight; signs of severe dehydration (dizziness, dark urine, dry mucous membranes); persistent ketonuria; electrolyte imbalance (sodium, potassium, magnesium); or altered mental status. Hyperemesis gravidarum is the most common cause of first-trimester hospitalization in developed countries. IV hydration, IV thiamine, parenteral antiemetics, and nutritional support are the basis of hospital treatment.
Related Reading
Deepen your knowledge with related articles